跳至主要内容
临床试验/NCT03757104
NCT03757104Unknown不适用

Home-based Interventions to Test and Start (HITS): a Cluster-randomized Controlled Trial to Reduce Mortality and Incidence Through HIV Treatment

Africa Health Research Institute1 个研究点 分布在 1 个国家目标入组 4,667 人开始时间: 2018年2月6日最近更新:
适应症
干预措施

试验速览

阶段
不适用
入组人数
4,667
试验地点
1
主要终点
Population-level HIV-related mortality in men

研究概览

简要总结

This study aims to establish the causal impact of two interventions - micro-incentives and a male-sensitive HIV- specific decision support app - on population-level HIV viral load and HIV-related mortality in men, as well as on population-based HIV incidence in young women.

详细描述

Research aim:

The primary aim of the home-based intervention to test and start (HITS) trial is to establish whether (i) the provision of two micro-incentives and (ii) a male-sensitive and HIV-specific decision support app will reduce population-level HIV viral load and HIV-related mortality in men, as well as population-level HIV incidence in young women.

Specific objectives

  1. Establish the causal impact of two micro-incentives (aimed at increasing uptake of home-based HIV testing and linkage to care, respectively) on:

  2. Population-level HIV viral load in men

  3. Population-level HIV-related mortality in men

  4. Population-level HIV incidence in young women.

  5. Establish the causal impact of a male-sensitive and HIV-specific decision- support app (called EPIC-HIV) on:

研究设计

研究类型
Interventional
分配方式
Randomized
干预模型
Factorial
主要目的
Health Services Research
盲法
None

入排标准

年龄范围
15 Years 至 —(Child, Adult, Older Adult)
性别
All
接受健康志愿者
是

入选标准

  • •15 years old and above
  • •Resident members of households within the Population Intervention Platform
  • •Have consented to participate in Population Intervention Platform
  • •additional eligibility criteria for EPIC-HIV

排除标准

  • •Refused to take part in Population Intervention Platform
  • •Participant reported to already be on ART

研究组 & 干预措施

micro-incentives

Experimental

micro-incentives only (8 communities)

干预措施: micro-incentive (Behavioral)

EPIC-HIV

Experimental

Empowered through informed choice for HIV [male sensitive HIV specific decision support app] (males only in 8 communities)

干预措施: EPIC-HIV (Behavioral)

micro-incentive and EPIC-HIV

Experimental

micro-incentives as well as EPIC [male sensitive HIV specific decision support app] (8 communities)

干预措施: micro-incentive and EPIC-HIV (Behavioral)

control

No Intervention

standard of care

结局指标

主要结局

Population-level HIV-related mortality in men

时间窗: year 3

Change in HIV-related mortality rate measured as the number of HIV-related deaths per 1000 person-years of observation in men

Population-level HIV incidence in young women (15-30 years of age)

时间窗: year 3

Change in HIV incidence rate (number of HIV sero-conversions per 100 person-years of follow up) in young women; HIV testing and viral load measurements are performed on the DBS samples collected during the annual survey

HIV testing uptake at point of test offer in men

时间窗: Baseline

% received the rapid HIV test at home among those offered the test in men

HIV treatment linkage at 1 year in men

时间窗: year 1

% who visited study clinics and initiated antiretroviral therapy (ART) in men

Population-level HIV viral suppression in men

时间窗: year 1

Change in proportion with detectable viremia in men; HIV testing and viral load measurements are performed on the dried blood spot (DBS) samples collected during the annual survey

次要结局

  • HIV treatment linkage at 1 year in women(year 1)
  • Retention in HIV care in men and women(year 3)
  • HIV testing uptake at point of test offer in women(Baseline)
  • Population-level HIV viral suppression (both sexes)(year 3)
  • Population-level HIV viral suppression in women(year 3)
  • Population-level HIV incidence in men(year 3)
  • HIV prevention knowledge in men and women(year 1)
  • Household wealth (food security)(year 3)
  • Partnership patterns in men and women(year 1)
  • Population-level HIV viral suppression in men(year 3)
  • Population-level all-cause mortality (both sexes)(year 3)
  • Reported condom use in men and women(year 1)
  • Hypertension healthcare utilization in men and women(year 1)
  • Population level HIV incidence (both sexes)(year 3)
  • Population-level HIV-related mortality (both sexes)(year 3)
  • Population-level HIV-related mortality in women(year 3)
  • HIV status knowledge in men and women(year 1)
  • HIV treatment utilization in men and women(year 1)
  • Patient viral suppression in men and women(year 3)
  • Tuberculosis (TB) healthcare utilization in men and women(year 1)
  • Diabetes Healthcare utilization in men and women(year 1)
  • Household wealth (household assets)(year 3)
  • Population-level HIV viral suppression (both sexes)(year 1)
  • Population-level HIV viral suppression in women(year 1)
  • Retention in HIV care in men and women(year 1)
  • Patient viral suppression in men and women(year 1)

研究者

申办方类型
Other
责任方
Principal Investigator
主要研究者

Frank

Professor

Africa Health Research Institute

研究点 (1)

Loading locations...

相似试验